Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;2(11):1036-42.
doi: 10.1016/S2215-0366(15)00332-6. Epub 2015 Sep 21.

Mental Health Research Priorities for Europe

Affiliations
Review

Mental Health Research Priorities for Europe

Til Wykes et al. Lancet Psychiatry. .

Abstract

Mental and brain disorders represent the greatest health burden to Europe-not only for directly affected individuals, but also for their caregivers and the wider society. They incur substantial economic costs through direct (and indirect) health-care and welfare spending, and via productivity losses, all of which substantially affect European development. Funding for research to mitigate these effects lags far behind the cost of mental and brain disorders to society. Here, we describe a comprehensive, coordinated mental health research agenda for Europe and worldwide. This agenda was based on systematic reviews of published work and consensus decision making by multidisciplinary scientific experts and affected stakeholders (more than 1000 in total): individuals with mental health problems and their families, health-care workers, policy makers, and funders. We generated six priorities that will, over the next 5-10 years, help to close the biggest gaps in mental health research in Europe, and in turn overcome the substantial challenges caused by mental disorders.

Similar articles

  • Cost of disorders of the brain in Europe 2010.
    Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group. Gustavsson A, et al. Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Eur Neuropsychopharmacol. 2011. PMID: 21924589
  • ROAMER: roadmap for mental health research in Europe.
    Haro JM, Ayuso-Mateos JL, Bitter I, Demotes-Mainard J, Leboyer M, Lewis SW, Linszen D, Maj M, McDaid D, Meyer-Lindenberg A, Robbins TW, Schumann G, Thornicroft G, Van Der Feltz-Cornelis C, Van Os J, Wahlbeck K, Wittchen HU, Wykes T, Arango C, Bickenbach J, Brunn M, Cammarata P, Chevreul K, Evans-Lacko S, Finocchiaro C, Fiorillo A, Forsman AK, Hazo JB, Knappe S, Kuepper R, Luciano M, Miret M, Obradors-Tarragó C, Pagano G, Papp S, Walker-Tilley T. Haro JM, et al. Int J Methods Psychiatr Res. 2014 Jan;23 Suppl 1(Suppl 1):1-14. doi: 10.1002/mpr.1406. Int J Methods Psychiatr Res. 2014. PMID: 24375532 Free PMC article.
  • A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F, Lewith G, Witt CM, Linde K, von Ammon K, Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, Weidenhammer W, Brinkhaus B. Fischer F, et al. Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24. Forsch Komplementmed. 2014. PMID: 24851850
  • The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU, Brown AK. Ekpu VU, et al. Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015. Tob Use Insights. 2015. PMID: 26242225 Free PMC article. Review.
  • Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force.
    Baulac M, de Boer H, Elger C, Glynn M, Kälviäinen R, Little A, Mifsud J, Perucca E, Pitkänen A, Ryvlin P. Baulac M, et al. Epilepsia. 2015 Nov;56(11):1687-95. doi: 10.1111/epi.13201. Epub 2015 Sep 28. Epilepsia. 2015. PMID: 26415919 Free PMC article. Review.
See all similar articles

Cited by 40 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback